Preprocedural C-Reactive Protein Levels Predict Stroke and Death in Patients Undergoing Carotid Stenting

References

1. ↵
   Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005;352:1685–95

   CrossRefPubMedWeb of Science
2. ↵
   Schillinger M, Exner M, Mlekusch W, et al. Inflammation and Carotid Artery-Risk for Atherosclerosis Study (ICARAS). Circulation 2005;111:2203–09

   Abstract/FREE Full Text
3. ↵
   Rerkasem K, Shearman CP, Williams JA, et al. C-reactive protein is elevated in symptomatic compared with asymptomatic patients with carotid artery disease. Eur J Vasc Endovasc Surg 2002;23:505–09

   CrossRefPubMedWeb of Science
4. ↵
   Alvarez Garcia B, Ruiz C, Chacon P, et al. High-sensitivity C-reactive protein in high-grade carotid stenosis: risk marker for unstable carotid plaque. J Vasc Surg 2003;38:1018–24

   CrossRefPubMedWeb of Science
5. ↵
   Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med 1991;325:445–53

   CrossRefPubMedWeb of Science
6. ↵
   Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST). Lancet 1998;351:1379–87

   CrossRefPubMedWeb of Science
7. ↵
   Ringleb PA, Allenberg J, Bruckmann H, et al. 30 day results from the SPACE trial of stent-protected angioplasty versus carotid endarterectomy in symptomatic patients: a randomised non-inferiority trial [published erratum appears in Lancet 2006;368:1238]. Lancet 2006;368:1239–47

   CrossRefPubMedWeb of Science
8. Goodney PP, Schermerhorn ML, Powell RJ. Current status of carotid artery stenting. J Vasc Surg 2006;43:406–11

   CrossRefPubMedWeb of Science
9. ↵
   Kastrup A, Gröschel K, Schulz JB, et al. Clinical predictors of transient ischemic attack, stroke, or death within 30 days of carotid angioplasty and stenting. Stroke 2005;36:787–91

   Abstract/FREE Full Text
10. ↵
    Yadav JS, Wholey MH, Kuntz RE, et al. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med 2004;351:1493–501

    CrossRefPubMedWeb of Science
11. ↵
    Buffon A, Liuzzo G, Biasucci LM, et al. Preprocedural serum levels of C-reactive protein predict early complications and late restenosis after coronary angioplasty. J Am Coll Cardiol 1999;34:1512–21

    CrossRefPubMedWeb of Science
12. Chew DP, Bhatt DL, Robbins MA, et al. Incremental prognostic value of elevated baseline C-reactive protein among established markers of risk in percutaneous coronary intervention. Circulation 2001;104:992–97

    Abstract/FREE Full Text
13. Dibra A, Mehilli J, Braun S, et al. Association between C-reactive protein levels and subsequent cardiac events among patients with stable angina treated with coronary artery stenting. Am J Med 2003;114:715–22

    CrossRefPubMedWeb of Science
14. ↵
    Goldberg A, Gruberg L, Roguin A, et al. Preprocedural C-reactive protein levels predict myocardial necrosis after successful coronary stenting in patients with stable angina. Am Heart J 2006;151:1265–70

    CrossRefPubMedWeb of Science
15. ↵
    Gröschel K, Ernemann U, Schulz JB, et al. Statin therapy at carotid angioplasty and stent placement: effect on procedure-related stroke, myocardial infarction, and death. Radiology 2006;240:145–51

    CrossRefPubMedWeb of Science
16. ↵
    Kastrup A, Schulz JB, Raygrotzki S, et al. Comparison of angioplasty and stenting with cerebral protection versus endarterectomy for treatment of internal carotid artery stenosis in elderly patients. J Vasc Surg 2004;40:945–51

    CrossRefPubMedWeb of Science
17. ↵
    Mathur A, Roubin GS, Iyer SS, et al. Predictors of stroke complicating carotid artery stenting. Circulation 1998;97:1239–45

    Abstract/FREE Full Text
18. ↵
    Jialal I, Stein D, Balis D, et al. Effect of hydroxymethyl glutaryl coenzyme a reductase inhibitor therapy on high sensitive C-reactive protein levels. Circulation 2001;103:1933–35

    Abstract/FREE Full Text
19. ↵
    Aronow HD, Shishehbor M, Davis DA, et al. Leukocyte count predicts microembolic Doppler signals during carotid stenting: a link between inflammation and embolization. Stroke 2005;36:1910–14

    Abstract/FREE Full Text
20. ↵
    Danesh J, Whincup P, Walker M, et al. Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BMJ 2000;321:199–204

    Abstract/FREE Full Text
21. ↵
    Lagrand WK, Visser CA, Hermens WT, et al. C-reactive protein as a cardiovascular risk factor: more than an epiphenomenon? Circulation 1999;100:96–102

    Abstract/FREE Full Text
22. ↵
    Mortensen RF. C-reactive protein, inflammation, and innate immunity. Immunol Res 2001;24:163–76

    CrossRefPubMedWeb of Science
23. ↵
    Cermak J, Key NS, Bach RR, et al. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood 1993;82:513–20

    Abstract/FREE Full Text
24. ↵
    Pasceri V, Willerson JT, Yeh ET. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 2000;102:2165–68

    Abstract/FREE Full Text